Skip To Main Content
Bart Jong on Muck Rack

Bart Jong

As seen in: JD Supra, Westlaw Today
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Bart

Contact Bart, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The EU Pharmaceutical Legislation: Why Regulatory Reform Matters for IP Teams

|
By Bart Jong, Jackie Mulryne
| JD Supra
The forthcoming EU General Pharmaceutical Legislation (GPL) is expected to be the most significant overhaul of the EU medicines framework in more than 20 years. Debate has focused on core regulatory questions such as shorter baseline protection, revised orphan incentives and new obligations intended to improve patient access.
Open in Who Shared View Duplicates (2) Issue with article?

The EU Pharmaceutical Legislation: Why Regulatory Reform Matters for IP Teams

|
By Tim Powell, Jackie Mulryne, Bart Jong
| Westlaw Today Verified
We've updated our Privacy Statement. Before you continue, please read our new Privacy Statement and familiarize yourself with the terms.
Open in Who Shared View Duplicates (343) Issue with article?

Preparing Deal Teams for the New EU Pharmaceutical Legislation

|
By Luciana Griebel, Bart Jong
| JD Supra
The European Union’s new pharmaceutical legislation, the most significant reform of the EU medicines framework in over two decades, will have important implications for M&A, licensing, and other life sciences transactions.
Open in Who Shared Issue with article?
See all 10 articles